Discontinued — last reported Q4 '17

Non-Current Assets

Intangibles (Net)

Stryker Intangibles (Net) decreased by 2.0% to $5.85B in Q3 2025 compared to the prior quarter. Year-over-year, this metric grew by 18.3%, from $4.94B to $5.85B. Over 4 years (FY 2020 to FY 2024), Intangibles (Net) shows a downward trend with a -5.7% CAGR.

Analysis

StatementBalance Sheet Statement
SectionNon-Current Assets
CategoryMarket Position
SignalContext dependent
VolatilityModerate
First reportedQ3 2015
Last reportedQ4 2017

How to read this metric

High levels reflect significant investment in growth through acquisitions; changes indicate the impact of amortization or impairment charges.

Detailed definition

This includes the value of acquired intellectual property, such as patents, trademarks, and drug licenses, net of accumu...

Peer comparison

Very high in the pharmaceutical industry due to the reliance on patent-protected drug portfolios.

Metric ID: intangible_assets_net

Historical Data

18 periods
 Q2 '21Q3 '21Q4 '21Q1 '22Q2 '22Q3 '22Q4 '22Q1 '23Q2 '23Q3 '23Q4 '23Q1 '24Q2 '24Q3 '24Q4 '24Q1 '25Q2 '25Q3 '25
Value$5.26B$5.06B$4.84B$5.43B$5.25B$5.05B$4.89B$4.78B$4.92B$4.73B$4.59B$4.51B$4.36B$4.94B$4.40B$6.13B$5.96B$5.85B
QoQ Change-3.9%-4.3%+12.2%-3.4%-3.7%-3.3%-2.2%+2.9%-3.8%-2.9%-1.8%-3.2%+13.2%-11.0%+39.5%-2.8%-2.0%
YoY Change-0.3%-0.1%+0.9%-12.0%-6.3%-6.4%-6.0%-5.6%-11.3%+4.4%-4.3%+36.0%+36.6%+18.3%
Range$4.36B$6.13B
CAGR+2.5%
Avg YoY Growth+3.1%
Median YoY Growth-2.3%
Current Streak2 quarters decline

Frequently Asked Questions

What is Stryker's intangibles (net)?
Stryker (SYK) reported intangibles (net) of $5.85B in Q3 2025.
How has Stryker's intangibles (net) changed year-over-year?
Stryker's intangibles (net) increased by 18.3% year-over-year, from $4.94B to $5.85B.
What is the long-term trend for Stryker's intangibles (net)?
Over 4 years (2020 to 2024), Stryker's intangibles (net) has grown at a -5.7% compound annual growth rate (CAGR), from $5.55B to $4.40B.
What does intangibles (net) mean?
The value of non-physical assets like patents and brand names, minus their amortized cost.

Cookie Preferences

We use cookies for analytics. See our Privacy and Cookie Policy.